CA9 and cancer: There, the data from 147 clinical studies encompassing more than 24,000 cancer patients were evaluated with respect to CA IX expression assessed by IHC in relationship to several endpoints, including overall survival (OS), disease-free survival (DFS), and progression-free survival (PFS).